US FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQWjV2Ny1fRVh5Y0RVX0MxVTZMS0xrUWxKUk9reEhUMkZZYm4tWXhCYkY1azBnNkFpVVFwN3BUMkJFZmRPQmVWX0l6RlhEd0RvdFphSkpYd2VuVktxT01HSGZIVDVqN3I1YUo5MGplRGlpSjhWZXdUZV9mMC0zZUFiR0NaUW9yTXpxNGs2elU1alZnSFN4cmRZeFEyREFDbVZEUmZ3aUdpcHI?oc=5" target="_blank">US FDA approves Bristol Myers' blood cancer treatment</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AMMerck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026 at 04:14 PMUS FDA extends review of Novo Nordisk's hemophilia drug over facility issues - Reuters
US FDA extends review of Novo Nordisk's hemophilia drug over facility issues Reuters
October 2, 2026 at 09:52 PMAstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up Reuters
September 28, 2026 at 10:15 PMAbbVie joins US government pilot to test drug discount rebates - Reuters
AbbVie joins US government pilot to test drug discount rebates Reuters
October 2, 2026 at 08:53 PM